208 related articles for article (PubMed ID: 26722456)
1. Prognostic role of PPAR-γ and PTEN in the renal cell carcinoma.
Zhu C; Wei J; Tian X; Li Y; Li X
Int J Clin Exp Pathol; 2015; 8(10):12668-77. PubMed ID: 26722456
[TBL] [Abstract][Full Text] [Related]
2. Activation of PI3K is associated with reduced survival in renal cell carcinoma.
Merseburger AS; Hennenlotter J; Kuehs U; Simon P; Kruck S; Koch E; Stenzl A; Kuczyk MA
Urol Int; 2008; 80(4):372-7. PubMed ID: 18587247
[TBL] [Abstract][Full Text] [Related]
3. PTEN/PI3K/AKT protein expression is related to clinicopathological features and prognosis in breast cancer with axillary lymph node metastases.
Wang LL; Hao S; Zhang S; Guo LJ; Hu CY; Zhang G; Gao B; Zhao JJ; Jiang Y; Tian WG; Wang J; Luo DL
Hum Pathol; 2017 Mar; 61():49-57. PubMed ID: 27864123
[TBL] [Abstract][Full Text] [Related]
4. PTEN expression in renal cell carcinoma and oncocytoma and prognosis.
Hager M; Haufe H; Kemmerling R; Mikuz G; Kolbitsch C; Moser PL
Pathology; 2007 Oct; 39(5):482-5. PubMed ID: 17886097
[TBL] [Abstract][Full Text] [Related]
5. [Correlation between the PTEN/MMAC1/TEP1 expression and cell proliferation and apoptosis in human renal cell carcinoma (RCC)].
Li JY; Cao RF; Wang H; Xie QX; Wang GX; Xiong LS; Miao YR
Ai Zheng; 2003 Jun; 22(6):607-11. PubMed ID: 12948410
[TBL] [Abstract][Full Text] [Related]
6. High expression of APRIL correlates with poor prognosis in clear cell renal cell carcinoma.
Lee C; Park JW; Suh JH; Moon KC
Pathol Res Pract; 2015 Nov; 211(11):824-8. PubMed ID: 26296917
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of BAP1, PBRM1, pS6, PTEN, TGase2, PD-L1, CA9, PSMA, and Ki-67 tissue markers in localized renal cell carcinoma: A retrospective study of tissue microarrays using immunohistochemistry.
Kim SH; Park WS; Park EY; Park B; Joo J; Joung JY; Seo HK; Lee KH; Chung J
PLoS One; 2017; 12(6):e0179610. PubMed ID: 28654655
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral expression of programmed death ligand 1 (PD-L1) in patients with clear cell renal cell carcinoma (ccRCC).
Abbas M; Steffens S; Bellut M; Eggers H; Großhennig A; Becker JU; Wegener G; Schrader AJ; Grünwald V; Ivanyi P
Med Oncol; 2016 Jul; 33(7):80. PubMed ID: 27317388
[TBL] [Abstract][Full Text] [Related]
9. The role of c-Met in prognosis and clinicopathology of renal cell carcinoma: Results from a single-centre study and systematic review.
Chen S; Zhu Y; Cui J; Wang Y; Xia Y; Song J; Cheng S; Zhou C; Zhang D; Zhang B; Shi B
Urol Oncol; 2017 Aug; 35(8):532.e15-532.e23. PubMed ID: 28427859
[TBL] [Abstract][Full Text] [Related]
10. ZFX is a Strong Predictor of Poor Prognosis in Renal Cell Carcinoma.
Li C; Li H; Zhang T; Li J; Ma F; Li M; Sui Z; Chang J
Med Sci Monit; 2015 Nov; 21():3380-5. PubMed ID: 26540164
[TBL] [Abstract][Full Text] [Related]
11. A novel prognostic model for patients with sarcomatoid renal cell carcinoma.
Zhang BY; Thompson RH; Lohse CM; Leibovich BC; Boorjian SA; Cheville JC; Costello BA
BJU Int; 2015 Mar; 115(3):405-11. PubMed ID: 24730416
[TBL] [Abstract][Full Text] [Related]
12. Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma.
Petraki CD; Gregorakis AK; Vaslamatzis MM; Papanastasiou PA; Yousef GM; Levesque MA; Diamandis EP
Tumour Biol; 2006; 27(1):1-7. PubMed ID: 16340244
[TBL] [Abstract][Full Text] [Related]
13. A four-gene signature predicts survival in clear-cell renal-cell carcinoma.
Dai J; Lu Y; Wang J; Yang L; Han Y; Wang Y; Yan D; Ruan Q; Wang S
Oncotarget; 2016 Dec; 7(50):82712-82726. PubMed ID: 27779101
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic expression of β-catenin is an independent predictor of progression of conventional renal cell carcinoma: a simple immunostaining score.
Kovacs G; Billfeldt NK; Farkas N; Dergez T; Javorhazy A; Banyai D; Pusztai C; Szanto A
Histopathology; 2017 Jan; 70(2):273-280. PubMed ID: 27501523
[TBL] [Abstract][Full Text] [Related]
15. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of mucin 18 is associated with unfavorable postoperative prognosis in patients with clear cell renal cell carcinoma.
Bai Q; Liu L; Long Q; Xia Y; Wang J; Xu J; Guo J
Int J Clin Exp Pathol; 2015; 8(9):11005-14. PubMed ID: 26617818
[TBL] [Abstract][Full Text] [Related]
17. Phosphatase and tensin homolog (PTEN) expression on oncologic outcome in renal cell carcinoma: A systematic review and meta-analysis.
Tang L; Li X; Gao Y; Chen L; Gu L; Chen J; Lyu X; Zhang Y; Zhang X
PLoS One; 2017; 12(7):e0179437. PubMed ID: 28672019
[TBL] [Abstract][Full Text] [Related]
18. [Multivariate analysis of prognostic factors in renal cell carcinoma].
Wang Y; Huang C; Wu Y; Gao G; Xin Y; Lin Z; Li X; Pan M
Zhonghua Wai Ke Za Zhi; 2000 Jun; 38(6):442-4. PubMed ID: 11832079
[TBL] [Abstract][Full Text] [Related]
19. Chromophobe renal cell carcinoma: the impact of tumor grade on outcome.
Cheville JC; Lohse CM; Sukov WR; Thompson RH; Leibovich BC
Am J Surg Pathol; 2012 Jun; 36(6):851-6. PubMed ID: 22367296
[TBL] [Abstract][Full Text] [Related]
20. Expression of molecular markers associated with the mammalian target of rapamycin pathway in nonmetastatic renal cell carcinoma: Effect on prognostic outcomes following radical nephrectomy.
Nishikawa M; Miyake H; Harada K; Fujisawa M
Urol Oncol; 2014 Jan; 32(1):49.e15-21. PubMed ID: 24239474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
